The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients
Condition(s):Covid19Last Updated:September 30, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Covid19Last Updated:September 30, 2021Unknown status
Condition(s):Covid19; LymphopeniaLast Updated:November 8, 2021Completed
Condition(s):COVID-19Last Updated:October 25, 2023Not yet recruiting
Condition(s):COVID-19Last Updated:October 8, 2020Unknown status
Condition(s):COVID-19Last Updated:October 4, 2023Not yet recruiting
Condition(s):COVID-19 (Coronavirus Disease 2019); COVID-19 Pandemic; COVID-19 Pneumonia; COVID-19 Respiratory Infection; COVID-19 Acute Respiratory Distress Syndrome; COVID-19-Associated Thromboembolism; COVID-19-Associated Pneumonia; COVID 19 Associated CoagulopathyLast Updated:December 19, 2023Recruiting
Condition(s):COVID-19; Prognostic Factors; PregnancyLast Updated:July 2, 2020Completed
Condition(s):Pregnancy Complications; Covid19Last Updated:March 22, 2023Recruiting
Condition(s):Covid19Last Updated:August 9, 2021Completed
Condition(s):SARS-CoV2 InfectionLast Updated:February 21, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.